Salt Lake City, August 28, 2025 — Leads & Copy — PolarityBio, a clinical-stage biotechnology firm, will participate in the Symposium on Advanced Wound Care (SAWC) Fall 2025 in Las Vegas, Nevada, from September 3-6, 2025. The company focuses on regenerative skin multicellular therapy.
John Stetson, CEO of PolarityBio, said the company is eager to share insights and explore regenerative technologies with clinicians, researchers, and strategic associates at SAWC.
SAWC Fall is a multidisciplinary wound care meeting in the U.S., featuring over 50 scientific sessions, 55 experts, and specialized educational tracks.
PolarityBio is focused on autologous skin regeneration. Its SkinTE® therapy is pursuing FDA BLA approval for diabetic foot ulcers (DFUs) and has Breakthrough Therapy and Regenerative Medicine Advanced Therapy Designations by the FDA. The Phase III COVER DFUS II study is expected to be completed in November 2025, with final data and BLA submission in the first half of 2026.
Wound healing leaders can contact connect@polaritybio.com to arrange meetings during the event.
Parker Scott, Investor Relations, IR@polaritybio.com, 801-455-1440
Jessica Starman, Media Contact, media@elev8newmedia.com
Source: PolarityBio
